FINWIRES · TerminalLIVE
FINWIRES

正午の上昇率上位銘柄

By

-- サギメット・バイオサイエンス（SGMT）は月曜日、臨床試験資金として約1億7500万ドルを調達するため、約2920万株の引受による株式発行を1株あたり6.00ドルで実施したと発表した。 株価は43%急騰し、日中取引量は1日平均約51万6000株から4520万株以上に急増した。 ベラデルミクス（MANE）は月曜日、軽度から中等度の男性型脱毛症患者を対象とした経口薬VDPHL01の第2/3相臨床試験パートAにおいて、主要評価項目および主要副次評価項目のすべてが「高い」統計的有意性で達成されたと発表した。 株価は32%急騰し、日中取引量は1日平均約44万6000株から250万株以上に急増した。 オルカ・セラピューティクス（ORKA）の株価は、同社が月曜日に発表した、中等度から重度の尋常性乾癬患者を対象とした第2a相臨床試験において、ORKA-001を投与された患者の約64%が16週時点で主要評価項目である皮膚病変の完全消失を達成したとの報告を受け、16%急騰した。 この日の取引高は510万株を超え、1日平均約76万株を大きく上回った。

Price: $8.36, Change: $+2.50, Percent Change: +42.58%

Related Articles

Research

Research Alert: Crane Tops Q1 Earnings; Oe Sales Acceleration Continues

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:CR delivered strong Q1 results with EPS of $1.65 (up 15% Y/Y), beating consensus expectations of $1.45. The outperformance prompted CR to raise full-year adjusted EPS guidance to $6.65-$6.85 from $6.55-$6.75, representing 12% growth at the midpoint. We attribute the beat and raise to successful integration of recent acquisitions and organic sales expansion within OE aerospace equipment. Aerospace remained the primary growth driver with 9.4% core sales growth to $318M, supported by 16% OEM growth and 14% backlog expansion reflecting favorable aircraft production ramp-ups. Process Flow Tech showed mixed results with a 0.6% organic sales decline offset by strong acquisition contributions, bringing total segment sales to $378M. We're encouraged by M&A activity following divestitures and believe CR's aerospace expansion will fuel additional earnings growth, though we expect near-term margin dilution before cost synergies materialize.

$CR
Insider Trading

Establishment Labs Holdings Insider Sold Shares Worth $4,919,478, According to a Recent SEC Filing

Juan Jose Chacon Quiros, Director, on April 23, 2026, sold 75,000 shares in Establishment Labs Holdings (ESTA) for $4,919,478. Following the Form 4 filing with the SEC, Chacon Quiros has control over a total of 1,152,697 common shares of the company, with 45,193 shares held directly and 1,107,504 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1688757/000174242926000015/xslF345X05/wk-form4_1777325917.xml

$ESTA
Research

Research Alert: Tfii Q1: Ltl Limps Along As Freight Market Strength Drives Strong Q2 Guidance

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Q1 EPS of $0.69 beat the internal target range of $0.50-$0.60 despite challenging conditions, while total revenue of $1.95B was essentially flat and operating income declined 15.7% to $96.6M. Operating margin contracted 100 bps to 5.7% amid volume pressures and $6.7M in incremental accident expenses. Segment results diverged sharply, with Truckload operating income up 14.3% to $55.8M and Logistics up 10.3% to $34.4M, while LTL struggled with operating income down 35.0% to $30.6M as margin compressed 220 bps to 4.7%. Management guided Q2 adjusted EPS to $1.50-$1.60, suggesting meaningful improvement in freight dynamics. The company raised its quarterly dividend 4.4% to $0.47 per share and generated free cash flow of $123.7M. We remain concerned about continued LTL weakness, as the segment's operating ratio deteriorated 220 bps to 95.3% amid softer industrial demand, tempering optimism from the stronger Q2 guidance.

$TFII